SCHEMBL8091213

SCHEMBL8091213

O=C(Nc1ccc(F)cc1)NS(=O)(=O)C1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.57
NPC1 O15118 5/20 0.57
EPHX1 P07099 1/20 0.57
TP53 P04637 1/20 0.50
CXCR2 P25025 1/20 0.49
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
CA4 P22748 1/20 0.49
CA7 P43166 1/20 0.49
ENPP3 O14638 3/20 0.46
ENPP1 P22413 2/20 0.46
ENPP2 Q13822 2/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TAAR1 Q96RJ0 1/20 0.45
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083387 0.85 RAB9A (0.57) RAB9ANPC1EPHX1CA12CA1
SCHEMBL8091184 0.85 RAB9A (0.57) RAB9ANPC1EPHX1CA12CA1
SCHEMBL19505872 0.84 ACP1 (0.57) RAB9AEPHX1TP53CA12CA1
SCHEMBL8089942 0.84 RAB9A (0.56) RAB9ANPC1EPHX1CA12CA1
SCHEMBL8095024 0.84 RAB9A (0.60) RAB9ANPC1EPHX1TP53CA12
SCHEMBL6466718 0.83 EPHX1 (0.58) RAB9AEPHX1TP53CA12CA1
SCHEMBL6465976 0.82 MEN1 (0.49) RAB9ANPC1EPHX1CA12CA1
SCHEMBL8089968 0.78 EPHX2 (0.57) RAB9ANPC1EPHX1CA12CA1
SCHEMBL23486705 0.78 RAB9A (0.53) RAB9ANPC1EPHX1TP53CA12
SCHEMBL8095054 0.76 EPHX2 (0.54) RAB9ANPC1EPHX1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US claimed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP claimed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP claimed
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed